Now Available: Download the podcasts of MSK video reports from AAOS 2008
With biweekly and special edition newsletters, Musculoskeletal Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment. MSK Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts.
|
Spondyloarthropathies:
Yeast Antibodies Predict More Severe AS
Patients with seronegative spondyloarthropathies, especially AS, who have high levels of antibodies to Saccharomyces cerevisiae are likely to have more severe disease and to need more anti-TNF therapy...
Arthritis:
Chronic TNF Response Sustains Inflammation but Partly Protects Bones
A newly-discovered autocrine loop in TNF-stimulated macrophages sustains expression of inflammatory mediators and sets up macrophages to respond to endogenous inflammatory factors, but may also protect bones...
Arthritis:
Should RA Patients Go Vegan?
A gluten-free, vegan diet may improve RA patients' cardiovascular risk profile...
Consumer News:
New Rheumatoid Arthritis Drug Works for Adults, Children
Two new studies have found tocilizumab to be effective in relieving the symptoms of RA in adults and children...
New from PubMed:
Diagnosis Delay in Patients with Ankylosing Spondylitis
Researchers have established new diagnostic criteria for ankylosing spondylitis in an effort to minimize the diagnosis delay in AS...
BioPharm Business:
UCB Reports That CHMP Upholds Negative Opinion on Cimzia (certolizumab pegol) for Crohn's Disease
The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has rejected UCB's appeal to have Cimzia (certolizumab pegol) approved for the treatment of Crohn's disease patients...
|